Update of the Belgian Association for the Study of the Liver Guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
作者： Stéphane de Maeght , Peter Starkel , Jean-Pierre Mulkay , Isabelle Colle , Jean Delwaide
DOI:
关键词:
摘要: (1) Department of Gastroenterology and Hepatology, AZ St. Jan AV Brugge-Oostende, Bruges, Belgium ; (2) Service d'Hepato-Gastroenterologie, Hopital de Jolimont, Haine-Saint-Paul, (3) University Hospital Antwerp, (4) Liver Biliopancreatic Disorders, Gasthuisberg, Catholic Leuven, (5) Hepatopancreatology, Erasme Hospital, Universite Libre Bruxelles, Brussels, (6) Gastroenterology, Stuivenberg, (7) Hepatology Ghent Ghent, (8) CHU Sart Tilman, Liege, (9) Hepatogastroenterology, Saint-Pierre, (10) d'Hepatologie, Cliniques Universitaires St-Luc UCL, Woluwe, (11) UZ Belgium.
ulb.ac.be
moleculardiagnostics.be 参考文章(64)
Shehan Hettiaratchy, Remo Papini, Initial management of a major burn: I—overview BMJ. ,vol. 328, pp. 1555- 1557 ,(2004) , 10.1136/BMJ.328.7455.1555
P. Deltenre, C. Moreno, A. Tran, I. Ollivier, F. Provôt, F. Stanke, M. Lazrek, H. Castel, V. Canva, A. Louvet, M. Colin, F. Glowacki, S. Dharancy, J. Henrion, M. Hazzan, C. Noel, P. Mathurin, Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 454- 461 ,(2011) , 10.1111/J.1365-2036.2011.04741.X
J Delwaide, H Van Vlierberghe, N Bourgeois, H Reynaert, Y Horsmans, Frederik Nevens, J Henrion, P Michielsen, R Brenard, Ch De Galocsy, D Sprengers, G Robaeys, Hepatitis C: screening, treatment and prevention practical guidelines. Acta Gastro-enterologica Belgica. ,vol. 66, pp. 15- 19 ,(2003)
Mark Sulkowski, Fred Poordad, Michael P. Manns, Jean-Pierre Bronowicki, Rajender Reddy, Stephen A. Harrison, Nezam Afdhal, Navdeep Boparai, Vilma Sniukiene, Margaret Burroughs, Janice K. Albrecht, Clifford A. Brass, Ira M. Jacobson, Anemia During Treatment With Peginterferon Alfa-2B/Ribavirin With or Without Boceprevir is Associated With Higher SVR Rates: Analysis of Previously Untreated and Previous-Treatment-Failure Patients Gastroenterology. ,vol. 140, pp. S- 941 ,(2011) , 10.1016/S0016-5085(11)63905-X
Zobair M. Younossi, Jeroen Aerssens, Stanislas Pol, Paul Pockros, Eric J. Lawitz, Stefan Zeuzem, Pietro Andreone, Stuart K. Roberts, Graham Foster, Roberto Focaccia, Andrzej Horban, Rolf van Heeswijk, Sandra De Meyer, Don Luo, Martyn C. Botfield, Maria Beumont-Mauviel, Gaston Picchio, Similar SVR Rates in IL28B CC, CT or TT Prior Relapser, Partial- or Null-Responder Patients Treated With Telaprevir/Peginterferon/Ribavirin: Retrospective Analysis of the Realize Study Gastroenterology. ,vol. 140, pp. S- 907 ,(2011) , 10.1016/S0016-5085(11)63767-0
C. M. Lange, C. Sarrazin, S. Zeuzem, Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy. Alimentary Pharmacology & Therapeutics. ,vol. 32, pp. 14- 28 ,(2010) , 10.1111/J.1365-2036.2010.04317.X
Christophe Hézode, Nicole Forestier, Geoffrey Dusheiko, Peter Ferenci, Stanislas Pol, Tobias Goeser, Jean-Pierre Bronowicki, Marc Bourlière, Shahin Gharakhanian, Leif Bengtsson, Lindsay McNair, Shelley George, Tara Kieffer, Ann Kwong, Robert S. Kauffman, John Alam, Jean-Michel Pawlotsky, Stefan Zeuzem, Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. The New England Journal of Medicine. ,vol. 360, pp. 1839- 1850 ,(2009) , 10.1056/NEJMOA0807650
M.S. Sulkowski, R. Reddy, N.H. Afdhal, A.M. Di Bisceglie, S. Zeuzem, F. Poordad, L. Bengtsson, C.I. Wright, R.S. Kauffman, N. Adda, 477 ANEMIA HAD NO EFFECT ON EFFICACY OUTCOMES IN TREATMENT-NAIVE PATIENTS WHO RECEIVED TELAPREVIR-BASED REGIMEN IN THE ADVANCE AND ILLUMINATE PHASE 3 STUDIES Journal of Hepatology. ,vol. 54, ,(2011) , 10.1016/S0168-8278(11)60479-0
Tara L. Kieffer, Christoph Sarrazin, Janice S. Miller, Martin W. Welker, Nicole Forestier, Hendrik W. Reesink, Ann D. Kwong, Stefan Zeuzem, Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. Hepatology. ,vol. 46, pp. 631- 639 ,(2007) , 10.1002/HEP.21781
Patrick R. Harrington, Wen Zeng, Lisa K. Naeger, Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment. Hepatology. ,vol. 55, pp. 1048- 1057 ,(2012) , 10.1002/HEP.24791